IRIS

CARLOMAGNO, FRANCESCA

CARLOMAGNO, FRANCESCA  

DIPARTIMENTO DI MEDICINA MOLECOLARE E BIOTECNOLOGIE MEDICHE  

Mostra records
Risultati 1 - 20 di 121 (tempo di esecuzione: 0.055 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
Molecular mechanisms of RET activation in human cancer 2.1 Contributo in volume (Capitolo o Saggio) 2002 Santoro, Massimo; Melillo, Rosa Marina; Carlomagno, F; Fusco, Alfredo; Vecchio, Giancarlo
Ret-mediated mitogenesis requires Src kinase activity. 1.1 Articolo in rivista 1999 Melillo, Rosa Marina; Barone, Mv; Lupoli, G; Cirafici, Am; Carlomagno, F; Visconti, R; Matoskova, B; Di Fiore, Pp; Vecchio, G; Fusco, Alfredo; Santoro, Massimo
Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2). 1.1 Articolo in rivista 2003 Carlomagno, F; Vitagliano, D; Guida, T; Basolo, F; Castellone, Md; Melillo, ROSA MARINA; Fusco, Alfredo; Santoro, Massimo
The extent of linkage disequilibrium in four populations with distinct demographic histories 1.1 Articolo in rivista 2000 Dunning, Am; Durocher, F; Healey, Cs; Teare, Md; Mcbride, Se; Carlomagno, Francesca; Xu, Cf; Dawson, E; Rhodes, S; Ueda, S; Lai, E; Luben, Rn; VAN RENSBURG, Ej; Mannermaa, A; Kataja, V; Rennart, G; Dunhami, ; Purvis, I; Easton, D; Ponder, Ba
Therapeutic strategies to target the receptor tyrosine kinase AXL in thyroid cancer 4.2 Abstract in Atti di convegno 2012 Gnanaprakasam, Krisnamoorthy; Guida, Teresa; Visciano, Carla; Liotti, Federica; Carlomagno, Francesca; Melillo, ROSA MARINA
Oncogenic rearrangements driving ionizing radiation-associated human cancer 1.1 Articolo in rivista 2013 Santoro, Massimo; Carlomagno, Francesca
Identification of Polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma. 1.1 Articolo in rivista 2009 Nappi, T.; Salerno, P.; Zitzelsberger, H.; Carlomagno, Francesca; Salvatore, G.; Santoro, Massimo
Molecular heterogeneity of RET loss of function in Hirschsprung's disease 1.1 Articolo in rivista 1996 Carlomagno, F.; DE VITA, Gabriella; Berlingieri, M. T.; Defranciscis, V.; Melillo, ROSA MARINA; Colantuoni, V.; Kraus, M. H.; Difiore, P. P.; Fusco, Alfredo; Santoro, M.
Drug insight: Small-molecule inhibitors of protein kinases in the treatment of thyroid cancer. 1.1 Articolo in rivista 2006 Santoro, Massimo; Carlomagno, Francesca
Constitutive and AP20187-induced Ret activation in photoreceptors does not protect from light-induced damage. 1.1 Articolo in rivista 2007 Allocca, M; DI VICINO, U; Petrillo, M; Carlomagno, Francesca; Domenici, L; Auricchio, Alberto
Activation of the Erk8 mitogen-activated protein (MAP) kinase by RET/PTC3, a constitutively active form of the RET proto-oncogene. 1.1 Articolo in rivista 2006 Iavarone, C; Acunzo, M; Carlomagno, Francesca; Catania, A; Melillo, ROSA MARINA; Carlomagno, MARIA STELLA; Santoro, Massimo; Chiariello, M.
RET\PTC activation in human thyroid carcinomas 1.1 Articolo in rivista 1995 Fusco, Alfredo; Santoro, Massimo; Grieco, M.; Carlomagno, Francesca; Dathan, N.; Fabien, N.; Berlingieri, M. T.; Li, Z.; de franciscis, V.; Salvatore, Domenico; Melillo, ROSA MARINA; Portella, Giuseppe; Cerrato, A.; Colantuoni, V.; Vecchio, Giancarlo
Attacking cancer with molecularly targeted agents 1.1 Articolo in rivista 2013 Santoro, Massimo; Carlomagno, Francesca
Molecular mechanisms of RET activation in human neoplasia 2.1 Contributo in volume (Capitolo o Saggio) 2002 Santoro, Massimo; Carlomagno, F; Melillo, Rosa Marina; Vecchio, Giancarlo; Fusco, Alfredo
Protein kinase Calpha activation by RET: evidence for a negative feedback mechanism controlling RET tyrosine kinase 1.1 Articolo in rivista 2003 Melillo, ROSA MARINA; Carlomagno, Francesca; Oriente, F; Miele, C; Fiory, Francesca; Santopietro, S; Castellone, Md; Beguinot, F; Santoro, Massimo; Formisano, Pietro
Basi molecolari delle nuove terapie: inibitori delle protein-chinasi. 2.1 Contributo in volume (Capitolo o Saggio) 2007 Santoro, Massimo; Salvatore, G.; Carlomagno, F.; Fusco, Alfredo
Ret-mediated mitogenesis requires Src kinase activity. 1.1 Articolo in rivista 1999 Melillo, Rm; Barone, MARIA VITTORIA; Lupoli, G; Cirafici, Am; Carlomagno, F; Visconti, R; Matoskova, B; Di Fiore, Pp; Vecchio, G; Fusco, A; Santoro, M.
The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes 1.1 Articolo in rivista 2002 Carlomagno, Francesca; Vitagliano, Donata; Guida, Teresa; Napolitano, M.; Vecchio, Giancarlo; Fusco, Alfredo; Gazit, A.; Levitzki, A.; Santoro, Massimo
Genetic Alterations in differentiated thyroid cancer:what can be expected for gene expression profiling of thyroid carcinomas 1.1 Articolo in rivista 2003 Santoro, Massimo; Melillo, ROSA MARINA; Carlomagno, Francesca; Castellone, MARIA DOMENICA; Vitagliano, Donata; Guida, Teresa; Vecchio, Giancarlo; Fusco, Alfredo
RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. 1.1 Articolo in rivista 1998 G., Tallini; Santoro, Massimo; M., Helie; Carlomagno, Francesca; G., Salvatore; G., Chiappetta; M. L., Carcangiu; Fusco, Alfredo